Transcatheter Aortic Valve Replacement in Severe Low Flow, Low Gradient Aortic Stenosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Salerno
About this trial
LOW-TAVR is a real-world, retrospective and prospective, multicenter Italian registry aimed at evaluating the characteristics and clinical outcomes of patients with severe low flow, low gradient aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) and, in particular:
* risk factors * gender differences * comorbidities * pharmacological treatment * TAVR procedural characteristics * periprocedural and in-hospital complications * clinical outcome at 30-day, 1-year, 2-year and 5-year follow-up
Eligibility criteria
Qualifiers
LFLG-AS diagnosis according to current European Society of Cardiology guidelines
Age 18 years or older
Written informed consent
Disqualifiers
LFLG-AS pseudo-severe or non-confirmed severe aortic stenosis
LFLG-AS referred for medical treatment or undergoing surgery
Trial design
Treatments tested in this trial
- Transcatheter aortic valve replacement
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov